nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A5—Cimetidine—obesity	0.0804	0.246	CbGbCtD
Vardenafil—CYP3A4—Sibutramine—obesity	0.0663	0.203	CbGbCtD
Vardenafil—CYP3A4—Benzphetamine—obesity	0.0502	0.154	CbGbCtD
Vardenafil—CYP3A4—Bupropion—obesity	0.0427	0.131	CbGbCtD
Vardenafil—CYP3A4—Orlistat—obesity	0.0348	0.107	CbGbCtD
Vardenafil—CYP3A4—Cimetidine—obesity	0.0313	0.0961	CbGbCtD
Vardenafil—CYP3A4—Topiramate—obesity	0.0205	0.0629	CbGbCtD
Vardenafil—PDE10A—respiratory system—obesity	0.00542	0.0746	CbGeAlD
Vardenafil—PDE11A—adrenal gland—obesity	0.00505	0.0695	CbGeAlD
Vardenafil—PDE6G—adrenal gland—obesity	0.00486	0.0669	CbGeAlD
Vardenafil—PDE11A—endocrine gland—obesity	0.00438	0.0603	CbGeAlD
Vardenafil—PDE6H—endocrine gland—obesity	0.00438	0.0603	CbGeAlD
Vardenafil—PDE11A—liver—obesity	0.00395	0.0543	CbGeAlD
Vardenafil—PDE6G—liver—obesity	0.0038	0.0523	CbGeAlD
Vardenafil—PDE10A—adipose tissue—obesity	0.00366	0.0504	CbGeAlD
Vardenafil—PDE1B—adipose tissue—obesity	0.00363	0.0499	CbGeAlD
Vardenafil—PDE10A—digestive system—obesity	0.00345	0.0474	CbGeAlD
Vardenafil—PDE10A—adrenal gland—obesity	0.00329	0.0452	CbGeAlD
Vardenafil—PDE1B—adrenal gland—obesity	0.00326	0.0448	CbGeAlD
Vardenafil—PDE5A—respiratory system—obesity	0.00317	0.0437	CbGeAlD
Vardenafil—PDE1B—endocrine gland—obesity	0.00282	0.0388	CbGeAlD
Vardenafil—PDE5A—cardiovascular system—obesity	0.00243	0.0334	CbGeAlD
Vardenafil—PDE5A—adipose tissue—obesity	0.00214	0.0295	CbGeAlD
Vardenafil—PDE5A—digestive system—obesity	0.00202	0.0278	CbGeAlD
Vardenafil—PDE5A—adrenal gland—obesity	0.00192	0.0264	CbGeAlD
Vardenafil—PDE5A—endocrine gland—obesity	0.00167	0.0229	CbGeAlD
Vardenafil—CYP3A5—islet of Langerhans—obesity	0.0014	0.0192	CbGeAlD
Vardenafil—CYP3A5—respiratory system—obesity	0.00132	0.0181	CbGeAlD
Vardenafil—Sildenafil—CYP2E1—obesity	0.000973	1	CrCbGaD
Vardenafil—CYP3A5—adipose tissue—obesity	0.00089	0.0122	CbGeAlD
Vardenafil—CYP3A5—digestive system—obesity	0.000838	0.0115	CbGeAlD
Vardenafil—CYP3A5—endocrine gland—obesity	0.000693	0.00953	CbGeAlD
Vardenafil—CYP3A4—digestive system—obesity	0.000629	0.00865	CbGeAlD
Vardenafil—CYP3A5—liver—obesity	0.000624	0.00859	CbGeAlD
Vardenafil—CYP3A4—endocrine gland—obesity	0.00052	0.00715	CbGeAlD
Vardenafil—Diarrhoea—Cimetidine—obesity	0.000513	0.00158	CcSEcCtD
Vardenafil—Angiopathy—Sibutramine—obesity	0.000511	0.00158	CcSEcCtD
Vardenafil—Mental disorder—Orlistat—obesity	0.00051	0.00157	CcSEcCtD
Vardenafil—Immune system disorder—Sibutramine—obesity	0.000509	0.00157	CcSEcCtD
Vardenafil—Eye pain—Topiramate—obesity	0.000501	0.00155	CcSEcCtD
Vardenafil—Vomiting—Diethylpropion—obesity	0.000501	0.00154	CcSEcCtD
Vardenafil—Nasal congestion—Topiramate—obesity	0.000497	0.00153	CcSEcCtD
Vardenafil—Rash—Diethylpropion—obesity	0.000497	0.00153	CcSEcCtD
Vardenafil—Dermatitis—Diethylpropion—obesity	0.000496	0.00153	CcSEcCtD
Vardenafil—Dizziness—Cimetidine—obesity	0.000496	0.00153	CcSEcCtD
Vardenafil—Haemoglobin—Bupropion—obesity	0.000494	0.00152	CcSEcCtD
Vardenafil—Headache—Diethylpropion—obesity	0.000493	0.00152	CcSEcCtD
Vardenafil—Rhinitis—Bupropion—obesity	0.000493	0.00152	CcSEcCtD
Vardenafil—Haemorrhage—Bupropion—obesity	0.000491	0.00152	CcSEcCtD
Vardenafil—Back pain—Orlistat—obesity	0.00049	0.00151	CcSEcCtD
Vardenafil—Hypoaesthesia—Bupropion—obesity	0.000489	0.00151	CcSEcCtD
Vardenafil—Pharyngitis—Bupropion—obesity	0.000488	0.0015	CcSEcCtD
Vardenafil—Muscle spasms—Orlistat—obesity	0.000487	0.0015	CcSEcCtD
Vardenafil—Urinary tract disorder—Bupropion—obesity	0.000485	0.0015	CcSEcCtD
Vardenafil—Hot flush—Topiramate—obesity	0.000484	0.00149	CcSEcCtD
Vardenafil—Connective tissue disorder—Bupropion—obesity	0.000483	0.00149	CcSEcCtD
Vardenafil—Urethral disorder—Bupropion—obesity	0.000482	0.00149	CcSEcCtD
Vardenafil—Amnesia—Topiramate—obesity	0.000482	0.00149	CcSEcCtD
Vardenafil—Menopausal symptoms—Topiramate—obesity	0.00048	0.00148	CcSEcCtD
Vardenafil—Vision blurred—Orlistat—obesity	0.000478	0.00147	CcSEcCtD
Vardenafil—Visual disturbance—Topiramate—obesity	0.000478	0.00147	CcSEcCtD
Vardenafil—Vomiting—Cimetidine—obesity	0.000477	0.00147	CcSEcCtD
Vardenafil—Back pain—Sibutramine—obesity	0.000475	0.00146	CcSEcCtD
Vardenafil—Visual impairment—Bupropion—obesity	0.000474	0.00146	CcSEcCtD
Vardenafil—Rash—Cimetidine—obesity	0.000473	0.00146	CcSEcCtD
Vardenafil—Dermatitis—Cimetidine—obesity	0.000472	0.00146	CcSEcCtD
Vardenafil—Muscle spasms—Sibutramine—obesity	0.000472	0.00145	CcSEcCtD
Vardenafil—Ill-defined disorder—Orlistat—obesity	0.00047	0.00145	CcSEcCtD
Vardenafil—Headache—Cimetidine—obesity	0.00047	0.00145	CcSEcCtD
Vardenafil—CYP3A4—liver—obesity	0.000469	0.00645	CbGeAlD
Vardenafil—Nausea—Diethylpropion—obesity	0.000468	0.00144	CcSEcCtD
Vardenafil—Angioedema—Orlistat—obesity	0.000463	0.00143	CcSEcCtD
Vardenafil—Vision blurred—Sibutramine—obesity	0.000462	0.00143	CcSEcCtD
Vardenafil—Eye disorder—Bupropion—obesity	0.000459	0.00142	CcSEcCtD
Vardenafil—Tinnitus—Bupropion—obesity	0.000458	0.00141	CcSEcCtD
Vardenafil—Malaise—Orlistat—obesity	0.000457	0.00141	CcSEcCtD
Vardenafil—Cardiac disorder—Bupropion—obesity	0.000456	0.00141	CcSEcCtD
Vardenafil—Flushing—Bupropion—obesity	0.000456	0.00141	CcSEcCtD
Vardenafil—Vertigo—Orlistat—obesity	0.000456	0.0014	CcSEcCtD
Vardenafil—Ill-defined disorder—Sibutramine—obesity	0.000455	0.0014	CcSEcCtD
Vardenafil—Angioedema—Sibutramine—obesity	0.000448	0.00138	CcSEcCtD
Vardenafil—Palpitations—Orlistat—obesity	0.000448	0.00138	CcSEcCtD
Vardenafil—Angiopathy—Bupropion—obesity	0.000446	0.00137	CcSEcCtD
Vardenafil—Nausea—Cimetidine—obesity	0.000445	0.00137	CcSEcCtD
Vardenafil—Immune system disorder—Bupropion—obesity	0.000444	0.00137	CcSEcCtD
Vardenafil—Mediastinal disorder—Bupropion—obesity	0.000443	0.00137	CcSEcCtD
Vardenafil—Malaise—Sibutramine—obesity	0.000442	0.00136	CcSEcCtD
Vardenafil—Vertigo—Sibutramine—obesity	0.000441	0.00136	CcSEcCtD
Vardenafil—Syncope—Sibutramine—obesity	0.00044	0.00136	CcSEcCtD
Vardenafil—Convulsion—Orlistat—obesity	0.000439	0.00135	CcSEcCtD
Vardenafil—Face oedema—Topiramate—obesity	0.000437	0.00135	CcSEcCtD
Vardenafil—Palpitations—Sibutramine—obesity	0.000434	0.00134	CcSEcCtD
Vardenafil—Myalgia—Orlistat—obesity	0.000432	0.00133	CcSEcCtD
Vardenafil—Chest pain—Orlistat—obesity	0.000432	0.00133	CcSEcCtD
Vardenafil—Loss of consciousness—Sibutramine—obesity	0.000431	0.00133	CcSEcCtD
Vardenafil—Mental disorder—Bupropion—obesity	0.000431	0.00133	CcSEcCtD
Vardenafil—Anxiety—Orlistat—obesity	0.00043	0.00133	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000429	0.00132	CcSEcCtD
Vardenafil—Discomfort—Orlistat—obesity	0.000426	0.00131	CcSEcCtD
Vardenafil—Convulsion—Sibutramine—obesity	0.000425	0.00131	CcSEcCtD
Vardenafil—Blood creatinine increased—Topiramate—obesity	0.000424	0.00131	CcSEcCtD
Vardenafil—Dry mouth—Orlistat—obesity	0.000422	0.0013	CcSEcCtD
Vardenafil—Liver function test abnormal—Topiramate—obesity	0.000418	0.00129	CcSEcCtD
Vardenafil—Chest pain—Sibutramine—obesity	0.000418	0.00129	CcSEcCtD
Vardenafil—Myalgia—Sibutramine—obesity	0.000418	0.00129	CcSEcCtD
Vardenafil—Arthralgia—Sibutramine—obesity	0.000418	0.00129	CcSEcCtD
Vardenafil—Anxiety—Sibutramine—obesity	0.000416	0.00128	CcSEcCtD
Vardenafil—Anaphylactic shock—Orlistat—obesity	0.000414	0.00128	CcSEcCtD
Vardenafil—Back pain—Bupropion—obesity	0.000414	0.00128	CcSEcCtD
Vardenafil—Abdominal pain upper—Topiramate—obesity	0.000413	0.00127	CcSEcCtD
Vardenafil—Orthostatic hypotension—Topiramate—obesity	0.000413	0.00127	CcSEcCtD
Vardenafil—Discomfort—Sibutramine—obesity	0.000413	0.00127	CcSEcCtD
Vardenafil—Muscle spasms—Bupropion—obesity	0.000411	0.00127	CcSEcCtD
Vardenafil—Infection—Orlistat—obesity	0.000411	0.00127	CcSEcCtD
Vardenafil—Breast disorder—Topiramate—obesity	0.000409	0.00126	CcSEcCtD
Vardenafil—Dry mouth—Sibutramine—obesity	0.000409	0.00126	CcSEcCtD
Vardenafil—Aspartate aminotransferase increased—Topiramate—obesity	0.000408	0.00126	CcSEcCtD
Vardenafil—Nervous system disorder—Orlistat—obesity	0.000406	0.00125	CcSEcCtD
Vardenafil—Vision blurred—Bupropion—obesity	0.000403	0.00124	CcSEcCtD
Vardenafil—Skin disorder—Orlistat—obesity	0.000402	0.00124	CcSEcCtD
Vardenafil—Gastritis—Topiramate—obesity	0.000401	0.00123	CcSEcCtD
Vardenafil—Anaphylactic shock—Sibutramine—obesity	0.0004	0.00123	CcSEcCtD
Vardenafil—Hyperhidrosis—Orlistat—obesity	0.0004	0.00123	CcSEcCtD
Vardenafil—Alanine aminotransferase increased—Topiramate—obesity	0.000399	0.00123	CcSEcCtD
Vardenafil—Infection—Sibutramine—obesity	0.000398	0.00123	CcSEcCtD
Vardenafil—Ill-defined disorder—Bupropion—obesity	0.000397	0.00122	CcSEcCtD
Vardenafil—Shock—Sibutramine—obesity	0.000394	0.00121	CcSEcCtD
Vardenafil—Dysphagia—Topiramate—obesity	0.000391	0.00121	CcSEcCtD
Vardenafil—Angioedema—Bupropion—obesity	0.000391	0.00121	CcSEcCtD
Vardenafil—Tachycardia—Sibutramine—obesity	0.000391	0.00121	CcSEcCtD
Vardenafil—Skin disorder—Sibutramine—obesity	0.000389	0.0012	CcSEcCtD
Vardenafil—Hyperhidrosis—Sibutramine—obesity	0.000387	0.00119	CcSEcCtD
Vardenafil—Malaise—Bupropion—obesity	0.000386	0.00119	CcSEcCtD
Vardenafil—Vertigo—Bupropion—obesity	0.000384	0.00118	CcSEcCtD
Vardenafil—Syncope—Bupropion—obesity	0.000384	0.00118	CcSEcCtD
Vardenafil—Angina pectoris—Topiramate—obesity	0.000381	0.00117	CcSEcCtD
Vardenafil—Palpitations—Bupropion—obesity	0.000378	0.00117	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Orlistat—obesity	0.000377	0.00116	CcSEcCtD
Vardenafil—Loss of consciousness—Bupropion—obesity	0.000376	0.00116	CcSEcCtD
Vardenafil—Insomnia—Orlistat—obesity	0.000374	0.00115	CcSEcCtD
Vardenafil—Hypotension—Sibutramine—obesity	0.000374	0.00115	CcSEcCtD
Vardenafil—Paraesthesia—Orlistat—obesity	0.000372	0.00115	CcSEcCtD
Vardenafil—Convulsion—Bupropion—obesity	0.000371	0.00114	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Sibutramine—obesity	0.000365	0.00112	CcSEcCtD
Vardenafil—Dyspepsia—Orlistat—obesity	0.000364	0.00112	CcSEcCtD
Vardenafil—Myalgia—Bupropion—obesity	0.000364	0.00112	CcSEcCtD
Vardenafil—Arthralgia—Bupropion—obesity	0.000364	0.00112	CcSEcCtD
Vardenafil—Chest pain—Bupropion—obesity	0.000364	0.00112	CcSEcCtD
Vardenafil—Anxiety—Bupropion—obesity	0.000363	0.00112	CcSEcCtD
Vardenafil—Insomnia—Sibutramine—obesity	0.000362	0.00112	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000362	0.00112	CcSEcCtD
Vardenafil—Discomfort—Bupropion—obesity	0.00036	0.00111	CcSEcCtD
Vardenafil—Paraesthesia—Sibutramine—obesity	0.00036	0.00111	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Orlistat—obesity	0.000357	0.0011	CcSEcCtD
Vardenafil—Dyspnoea—Sibutramine—obesity	0.000357	0.0011	CcSEcCtD
Vardenafil—Photosensitivity reaction—Topiramate—obesity	0.000357	0.0011	CcSEcCtD
Vardenafil—Dry mouth—Bupropion—obesity	0.000356	0.0011	CcSEcCtD
Vardenafil—Somnolence—Sibutramine—obesity	0.000356	0.0011	CcSEcCtD
Vardenafil—Pain—Orlistat—obesity	0.000354	0.00109	CcSEcCtD
Vardenafil—Dyspepsia—Sibutramine—obesity	0.000353	0.00109	CcSEcCtD
Vardenafil—Anaphylactic shock—Bupropion—obesity	0.000349	0.00108	CcSEcCtD
Vardenafil—Infestation—Topiramate—obesity	0.000349	0.00108	CcSEcCtD
Vardenafil—Infestation NOS—Topiramate—obesity	0.000349	0.00108	CcSEcCtD
Vardenafil—Infection—Bupropion—obesity	0.000347	0.00107	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Sibutramine—obesity	0.000346	0.00107	CcSEcCtD
Vardenafil—Shock—Bupropion—obesity	0.000343	0.00106	CcSEcCtD
Vardenafil—Pain—Sibutramine—obesity	0.000342	0.00106	CcSEcCtD
Vardenafil—Nervous system disorder—Bupropion—obesity	0.000342	0.00106	CcSEcCtD
Vardenafil—Feeling abnormal—Orlistat—obesity	0.000341	0.00105	CcSEcCtD
Vardenafil—Tachycardia—Bupropion—obesity	0.000341	0.00105	CcSEcCtD
Vardenafil—Skin disorder—Bupropion—obesity	0.000339	0.00105	CcSEcCtD
Vardenafil—Conjunctivitis—Topiramate—obesity	0.000339	0.00105	CcSEcCtD
Vardenafil—Gastrointestinal pain—Orlistat—obesity	0.000338	0.00104	CcSEcCtD
Vardenafil—Hyperhidrosis—Bupropion—obesity	0.000337	0.00104	CcSEcCtD
Vardenafil—Haematuria—Topiramate—obesity	0.000333	0.00103	CcSEcCtD
Vardenafil—Feeling abnormal—Sibutramine—obesity	0.00033	0.00102	CcSEcCtD
Vardenafil—Epistaxis—Topiramate—obesity	0.000329	0.00101	CcSEcCtD
Vardenafil—Gastrointestinal pain—Sibutramine—obesity	0.000327	0.00101	CcSEcCtD
Vardenafil—Sinusitis—Topiramate—obesity	0.000327	0.00101	CcSEcCtD
Vardenafil—Abdominal pain—Orlistat—obesity	0.000327	0.00101	CcSEcCtD
Vardenafil—Hypotension—Bupropion—obesity	0.000326	0.00101	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Bupropion—obesity	0.000318	0.000981	CcSEcCtD
Vardenafil—Abdominal pain—Sibutramine—obesity	0.000317	0.000976	CcSEcCtD
Vardenafil—Insomnia—Bupropion—obesity	0.000316	0.000974	CcSEcCtD
Vardenafil—Haemoglobin—Topiramate—obesity	0.000315	0.00097	CcSEcCtD
Vardenafil—Rhinitis—Topiramate—obesity	0.000314	0.000968	CcSEcCtD
Vardenafil—Paraesthesia—Bupropion—obesity	0.000313	0.000967	CcSEcCtD
Vardenafil—Haemorrhage—Topiramate—obesity	0.000313	0.000965	CcSEcCtD
Vardenafil—Hypoaesthesia—Topiramate—obesity	0.000311	0.00096	CcSEcCtD
Vardenafil—Dyspnoea—Bupropion—obesity	0.000311	0.00096	CcSEcCtD
Vardenafil—Pharyngitis—Topiramate—obesity	0.000311	0.000958	CcSEcCtD
Vardenafil—Somnolence—Bupropion—obesity	0.00031	0.000957	CcSEcCtD
Vardenafil—Urinary tract disorder—Topiramate—obesity	0.000309	0.000953	CcSEcCtD
Vardenafil—Connective tissue disorder—Topiramate—obesity	0.000308	0.000949	CcSEcCtD
Vardenafil—Dyspepsia—Bupropion—obesity	0.000307	0.000948	CcSEcCtD
Vardenafil—Urethral disorder—Topiramate—obesity	0.000307	0.000946	CcSEcCtD
Vardenafil—Hypersensitivity—Orlistat—obesity	0.000305	0.00094	CcSEcCtD
Vardenafil—Visual impairment—Topiramate—obesity	0.000302	0.00093	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Bupropion—obesity	0.000301	0.000929	CcSEcCtD
Vardenafil—Pain—Bupropion—obesity	0.000299	0.00092	CcSEcCtD
Vardenafil—Asthenia—Orlistat—obesity	0.000297	0.000915	CcSEcCtD
Vardenafil—Hypersensitivity—Sibutramine—obesity	0.000295	0.00091	CcSEcCtD
Vardenafil—Pruritus—Orlistat—obesity	0.000293	0.000903	CcSEcCtD
Vardenafil—Eye disorder—Topiramate—obesity	0.000293	0.000902	CcSEcCtD
Vardenafil—Tinnitus—Topiramate—obesity	0.000292	0.0009	CcSEcCtD
Vardenafil—Cardiac disorder—Topiramate—obesity	0.000291	0.000896	CcSEcCtD
Vardenafil—Flushing—Topiramate—obesity	0.000291	0.000896	CcSEcCtD
Vardenafil—Feeling abnormal—Bupropion—obesity	0.000288	0.000887	CcSEcCtD
Vardenafil—Asthenia—Sibutramine—obesity	0.000287	0.000886	CcSEcCtD
Vardenafil—Gastrointestinal pain—Bupropion—obesity	0.000285	0.00088	CcSEcCtD
Vardenafil—Angiopathy—Topiramate—obesity	0.000284	0.000876	CcSEcCtD
Vardenafil—Pruritus—Sibutramine—obesity	0.000283	0.000874	CcSEcCtD
Vardenafil—Diarrhoea—Orlistat—obesity	0.000283	0.000873	CcSEcCtD
Vardenafil—Immune system disorder—Topiramate—obesity	0.000283	0.000872	CcSEcCtD
Vardenafil—Mediastinal disorder—Topiramate—obesity	0.000282	0.00087	CcSEcCtD
Vardenafil—Abdominal pain—Bupropion—obesity	0.000276	0.000851	CcSEcCtD
Vardenafil—Mental disorder—Topiramate—obesity	0.000274	0.000846	CcSEcCtD
Vardenafil—Diarrhoea—Sibutramine—obesity	0.000274	0.000845	CcSEcCtD
Vardenafil—Dizziness—Orlistat—obesity	0.000274	0.000844	CcSEcCtD
Vardenafil—Erythema—Topiramate—obesity	0.000273	0.00084	CcSEcCtD
Vardenafil—Dizziness—Sibutramine—obesity	0.000265	0.000816	CcSEcCtD
Vardenafil—Back pain—Topiramate—obesity	0.000264	0.000813	CcSEcCtD
Vardenafil—Vomiting—Orlistat—obesity	0.000263	0.000811	CcSEcCtD
Vardenafil—Muscle spasms—Topiramate—obesity	0.000262	0.000808	CcSEcCtD
Vardenafil—Rash—Orlistat—obesity	0.000261	0.000804	CcSEcCtD
Vardenafil—Dermatitis—Orlistat—obesity	0.000261	0.000804	CcSEcCtD
Vardenafil—Headache—Orlistat—obesity	0.000259	0.000799	CcSEcCtD
Vardenafil—Hypersensitivity—Bupropion—obesity	0.000257	0.000793	CcSEcCtD
Vardenafil—Vision blurred—Topiramate—obesity	0.000257	0.000792	CcSEcCtD
Vardenafil—Vomiting—Sibutramine—obesity	0.000255	0.000785	CcSEcCtD
Vardenafil—Ill-defined disorder—Topiramate—obesity	0.000253	0.00078	CcSEcCtD
Vardenafil—Rash—Sibutramine—obesity	0.000252	0.000779	CcSEcCtD
Vardenafil—Dermatitis—Sibutramine—obesity	0.000252	0.000778	CcSEcCtD
Vardenafil—Headache—Sibutramine—obesity	0.000251	0.000773	CcSEcCtD
Vardenafil—Asthenia—Bupropion—obesity	0.00025	0.000772	CcSEcCtD
Vardenafil—Pruritus—Bupropion—obesity	0.000247	0.000762	CcSEcCtD
Vardenafil—Nausea—Orlistat—obesity	0.000246	0.000758	CcSEcCtD
Vardenafil—Malaise—Topiramate—obesity	0.000246	0.000758	CcSEcCtD
Vardenafil—Vertigo—Topiramate—obesity	0.000245	0.000755	CcSEcCtD
Vardenafil—Syncope—Topiramate—obesity	0.000244	0.000754	CcSEcCtD
Vardenafil—Palpitations—Topiramate—obesity	0.000241	0.000743	CcSEcCtD
Vardenafil—Loss of consciousness—Topiramate—obesity	0.00024	0.000739	CcSEcCtD
Vardenafil—Diarrhoea—Bupropion—obesity	0.000239	0.000736	CcSEcCtD
Vardenafil—Nausea—Sibutramine—obesity	0.000238	0.000733	CcSEcCtD
Vardenafil—Convulsion—Topiramate—obesity	0.000236	0.000728	CcSEcCtD
Vardenafil—Arthralgia—Topiramate—obesity	0.000232	0.000715	CcSEcCtD
Vardenafil—Myalgia—Topiramate—obesity	0.000232	0.000715	CcSEcCtD
Vardenafil—Chest pain—Topiramate—obesity	0.000232	0.000715	CcSEcCtD
Vardenafil—Anxiety—Topiramate—obesity	0.000231	0.000713	CcSEcCtD
Vardenafil—Dizziness—Bupropion—obesity	0.000231	0.000712	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.00023	0.00071	CcSEcCtD
Vardenafil—Discomfort—Topiramate—obesity	0.000229	0.000707	CcSEcCtD
Vardenafil—Dry mouth—Topiramate—obesity	0.000227	0.0007	CcSEcCtD
Vardenafil—Vomiting—Bupropion—obesity	0.000222	0.000684	CcSEcCtD
Vardenafil—Infection—Topiramate—obesity	0.000221	0.000681	CcSEcCtD
Vardenafil—Rash—Bupropion—obesity	0.00022	0.000679	CcSEcCtD
Vardenafil—Dermatitis—Bupropion—obesity	0.00022	0.000678	CcSEcCtD
Vardenafil—Shock—Topiramate—obesity	0.000219	0.000675	CcSEcCtD
Vardenafil—Headache—Bupropion—obesity	0.000219	0.000674	CcSEcCtD
Vardenafil—Nervous system disorder—Topiramate—obesity	0.000218	0.000673	CcSEcCtD
Vardenafil—Tachycardia—Topiramate—obesity	0.000217	0.000669	CcSEcCtD
Vardenafil—Skin disorder—Topiramate—obesity	0.000216	0.000666	CcSEcCtD
Vardenafil—Hyperhidrosis—Topiramate—obesity	0.000215	0.000663	CcSEcCtD
Vardenafil—Hypotension—Topiramate—obesity	0.000208	0.000641	CcSEcCtD
Vardenafil—Nausea—Bupropion—obesity	0.000207	0.000639	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Topiramate—obesity	0.000203	0.000625	CcSEcCtD
Vardenafil—Insomnia—Topiramate—obesity	0.000201	0.00062	CcSEcCtD
Vardenafil—Paraesthesia—Topiramate—obesity	0.0002	0.000616	CcSEcCtD
Vardenafil—Dyspnoea—Topiramate—obesity	0.000198	0.000611	CcSEcCtD
Vardenafil—Somnolence—Topiramate—obesity	0.000198	0.00061	CcSEcCtD
Vardenafil—Dyspepsia—Topiramate—obesity	0.000196	0.000604	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Topiramate—obesity	0.000192	0.000592	CcSEcCtD
Vardenafil—Pain—Topiramate—obesity	0.00019	0.000586	CcSEcCtD
Vardenafil—Feeling abnormal—Topiramate—obesity	0.000183	0.000565	CcSEcCtD
Vardenafil—Gastrointestinal pain—Topiramate—obesity	0.000182	0.000561	CcSEcCtD
Vardenafil—Abdominal pain—Topiramate—obesity	0.000176	0.000542	CcSEcCtD
Vardenafil—Hypersensitivity—Topiramate—obesity	0.000164	0.000505	CcSEcCtD
Vardenafil—Asthenia—Topiramate—obesity	0.00016	0.000492	CcSEcCtD
Vardenafil—Pruritus—Topiramate—obesity	0.000157	0.000485	CcSEcCtD
Vardenafil—Diarrhoea—Topiramate—obesity	0.000152	0.000469	CcSEcCtD
Vardenafil—Dizziness—Topiramate—obesity	0.000147	0.000453	CcSEcCtD
Vardenafil—Vomiting—Topiramate—obesity	0.000141	0.000436	CcSEcCtD
Vardenafil—Rash—Topiramate—obesity	0.00014	0.000432	CcSEcCtD
Vardenafil—Dermatitis—Topiramate—obesity	0.00014	0.000432	CcSEcCtD
Vardenafil—Headache—Topiramate—obesity	0.000139	0.00043	CcSEcCtD
Vardenafil—Nausea—Topiramate—obesity	0.000132	0.000407	CcSEcCtD
Vardenafil—PDE11A—Signaling Pathways—MYC—obesity	1.81e-05	6.57e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PRKCD—obesity	1.81e-05	6.57e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TGFB1—obesity	1.81e-05	6.56e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TYK2—obesity	1.8e-05	6.52e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—STAT3—obesity	1.78e-05	6.47e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—RHOA—obesity	1.78e-05	6.46e-05	CbGpPWpGaD
Vardenafil—PDE6G—Disease—IL6—obesity	1.78e-05	6.45e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HTR2A—obesity	1.77e-05	6.43e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—C3—obesity	1.77e-05	6.42e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CLOCK—obesity	1.77e-05	6.41e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SLC22A1—obesity	1.77e-05	6.41e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PIK3R1—obesity	1.76e-05	6.4e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NOS3—obesity	1.76e-05	6.4e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MTOR—obesity	1.76e-05	6.39e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PIK3CB—obesity	1.76e-05	6.39e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—STAT3—obesity	1.74e-05	6.3e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—COX7C—obesity	1.73e-05	6.27e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—UCP1—obesity	1.73e-05	6.27e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PNPLA3—obesity	1.73e-05	6.27e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SULT2A1—obesity	1.72e-05	6.24e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GLP1R—obesity	1.72e-05	6.24e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—DPYD—obesity	1.69e-05	6.14e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IRS2—obesity	1.68e-05	6.11e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AGT—obesity	1.68e-05	6.1e-05	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—AKT1—obesity	1.67e-05	6.07e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MYC—obesity	1.66e-05	6.01e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TGFB1—obesity	1.65e-05	6e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APOE—obesity	1.65e-05	5.98e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—LEP—obesity	1.65e-05	5.98e-05	CbGpPWpGaD
Vardenafil—PDE6G—Disease—AKT1—obesity	1.64e-05	5.95e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—DGAT2—obesity	1.64e-05	5.94e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CS—obesity	1.64e-05	5.94e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CPS1—obesity	1.64e-05	5.94e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SUCLA2—obesity	1.64e-05	5.94e-05	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—IL6—obesity	1.63e-05	5.93e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CAV1—obesity	1.63e-05	5.92e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PRKAR2B—obesity	1.63e-05	5.91e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APOA1—obesity	1.63e-05	5.91e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PIK3CB—obesity	1.63e-05	5.9e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MTOR—obesity	1.63e-05	5.9e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL1B—obesity	1.63e-05	5.89e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—DCN—obesity	1.62e-05	5.87e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MYC—obesity	1.62e-05	5.86e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PTGS2—obesity	1.61e-05	5.85e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TGFB1—obesity	1.61e-05	5.84e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CPT1A—obesity	1.57e-05	5.71e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ESR1—obesity	1.57e-05	5.71e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LIPE—obesity	1.56e-05	5.67e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MUT—obesity	1.56e-05	5.67e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PRKCB—obesity	1.55e-05	5.64e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—F2—obesity	1.55e-05	5.64e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NAMPT—obesity	1.54e-05	5.6e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PIK3CA—obesity	1.54e-05	5.58e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—BAD—obesity	1.54e-05	5.57e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GCK—obesity	1.53e-05	5.57e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LIPC—obesity	1.53e-05	5.57e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOC3—obesity	1.53e-05	5.53e-05	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—AKT1—obesity	1.51e-05	5.47e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—DGAT1—obesity	1.5e-05	5.44e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYB5A—obesity	1.5e-05	5.44e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MAPK8—obesity	1.49e-05	5.41e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CG—obesity	1.49e-05	5.4e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CETP—obesity	1.48e-05	5.37e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IRS1—obesity	1.47e-05	5.33e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SDC1—obesity	1.46e-05	5.31e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ACLY—obesity	1.44e-05	5.23e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AKR1C3—obesity	1.44e-05	5.22e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SCARB1—obesity	1.42e-05	5.14e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—POMC—obesity	1.42e-05	5.14e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—INS—obesity	1.41e-05	5.11e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PIK3CA—obesity	1.41e-05	5.1e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ENPP1—obesity	1.39e-05	5.05e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALOX12—obesity	1.39e-05	5.05e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCL2—obesity	1.39e-05	5.02e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SREBF1—obesity	1.38e-05	4.99e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PIK3CA—obesity	1.37e-05	4.97e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—STAT3—obesity	1.36e-05	4.94e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL6—obesity	1.36e-05	4.94e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IGF1—obesity	1.36e-05	4.94e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKT2—obesity	1.36e-05	4.94e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HMGCS1—obesity	1.35e-05	4.9e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GOT2—obesity	1.34e-05	4.86e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ACADM—obesity	1.31e-05	4.75e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PNPLA2—obesity	1.31e-05	4.75e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PFKFB3—obesity	1.31e-05	4.75e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ANGPTL4—obesity	1.31e-05	4.75e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SAT1—obesity	1.31e-05	4.75e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PLIN1—obesity	1.31e-05	4.75e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—FASN—obesity	1.31e-05	4.75e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CD—obesity	1.31e-05	4.74e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—BCHE—obesity	1.3e-05	4.73e-05	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PIK3CA—obesity	1.3e-05	4.7e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SERPINE1—obesity	1.29e-05	4.69e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ACACB—obesity	1.27e-05	4.62e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—OXCT1—obesity	1.27e-05	4.62e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYTB—obesity	1.27e-05	4.62e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP2E1—obesity	1.26e-05	4.57e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TYK2—obesity	1.26e-05	4.56e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—STAT3—obesity	1.26e-05	4.56e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—AKT1—obesity	1.26e-05	4.56e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RHOA—obesity	1.25e-05	4.53e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL6—obesity	1.25e-05	4.52e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NQO1—obesity	1.24e-05	4.51e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PNLIP—obesity	1.24e-05	4.51e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SRD5A1—obesity	1.24e-05	4.51e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3R1—obesity	1.23e-05	4.48e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NOS3—obesity	1.23e-05	4.48e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL6—obesity	1.21e-05	4.4e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SDC3—obesity	1.21e-05	4.4e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GCG—obesity	1.19e-05	4.33e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SLC2A4—obesity	1.19e-05	4.33e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP26B1—obesity	1.18e-05	4.3e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HK2—obesity	1.18e-05	4.3e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—STS—obesity	1.18e-05	4.3e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYCS—obesity	1.18e-05	4.27e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PIK3CA—obesity	1.18e-05	4.27e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MYC—obesity	1.17e-05	4.24e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TGFB1—obesity	1.17e-05	4.23e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARD—obesity	1.16e-05	4.21e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GGT1—obesity	1.16e-05	4.19e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GOT1—obesity	1.16e-05	4.19e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—AKT1—obesity	1.15e-05	4.17e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MTOR—obesity	1.14e-05	4.13e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CB—obesity	1.14e-05	4.13e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NCOA1—obesity	1.14e-05	4.13e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC27A1—obesity	1.14e-05	4.12e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—STK11—obesity	1.12e-05	4.07e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP19A1—obesity	1.12e-05	4.07e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—AKT1—obesity	1.12e-05	4.06e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—FABP4—obesity	1.11e-05	4.04e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GLUL—obesity	1.11e-05	4.04e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PIK3CA—obesity	1.07e-05	3.9e-05	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AKT1—obesity	1.06e-05	3.84e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ECHS1—obesity	1.06e-05	3.83e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—UCP3—obesity	1.06e-05	3.83e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—UCP2—obesity	1.06e-05	3.83e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HSD11B1—obesity	1.06e-05	3.83e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—COMT—obesity	1.04e-05	3.78e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL6—obesity	1.04e-05	3.78e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ADH1B—obesity	1.04e-05	3.77e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GNB3—obesity	1.03e-05	3.73e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPARGC1A—obesity	1.03e-05	3.73e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HMOX1—obesity	1.02e-05	3.71e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARGC1B—obesity	1.02e-05	3.71e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ACSL1—obesity	1.02e-05	3.71e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GPAM—obesity	1.02e-05	3.71e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GNAS—obesity	1e-05	3.63e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HADH—obesity	9.93e-06	3.6e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—FADS1—obesity	9.93e-06	3.6e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PCK1—obesity	9.93e-06	3.6e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PIK3CA—obesity	9.92e-06	3.6e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MMP9—obesity	9.91e-06	3.59e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOB—obesity	9.81e-06	3.56e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ACP5—obesity	9.66e-06	3.5e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAPK8—obesity	9.64e-06	3.49e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AKT1—obesity	9.61e-06	3.49e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL6—obesity	9.52e-06	3.45e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—G6PD—obesity	9.41e-06	3.41e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LPL—obesity	9.36e-06	3.4e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SREBF2—obesity	9.3e-06	3.37e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HK1—obesity	9.3e-06	3.37e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GPX1—obesity	9.14e-06	3.31e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LPA—obesity	8.98e-06	3.26e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CD36—obesity	8.9e-06	3.23e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—STAT3—obesity	8.81e-06	3.19e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LPIN1—obesity	8.79e-06	3.19e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IL6—obesity	8.79e-06	3.19e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—AKT1—obesity	8.78e-06	3.18e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOA5—obesity	8.61e-06	3.12e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MTHFR—obesity	8.43e-06	3.06e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPARA—obesity	8.27e-06	3e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CLOCK—obesity	8.21e-06	2.98e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC22A1—obesity	8.21e-06	2.98e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MYC—obesity	8.19e-06	2.97e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TGFB1—obesity	8.17e-06	2.96e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—AKT1—obesity	8.11e-06	2.94e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AGT—obesity	8.01e-06	2.91e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SULT2A1—obesity	8e-06	2.9e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GLP1R—obesity	8e-06	2.9e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—DPYD—obesity	7.87e-06	2.86e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOE—obesity	7.85e-06	2.85e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CAV1—obesity	7.78e-06	2.82e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOA1—obesity	7.76e-06	2.81e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PRKAR2B—obesity	7.58e-06	2.75e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—DCN—obesity	7.53e-06	2.73e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CPT1A—obesity	7.32e-06	2.66e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NAMPT—obesity	7.18e-06	2.6e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LIPC—obesity	7.13e-06	2.59e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GCK—obesity	7.13e-06	2.59e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOC3—obesity	7.09e-06	2.57e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CG—obesity	7.08e-06	2.57e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CA—obesity	6.95e-06	2.52e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CETP—obesity	6.88e-06	2.5e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPARG—obesity	6.84e-06	2.48e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SDC1—obesity	6.81e-06	2.47e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—POMC—obesity	6.74e-06	2.45e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—INS—obesity	6.71e-06	2.43e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AKR1C3—obesity	6.7e-06	2.43e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SCARB1—obesity	6.59e-06	2.39e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SREBF1—obesity	6.4e-06	2.32e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CD—obesity	6.23e-06	2.26e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GOT2—obesity	6.22e-06	2.26e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL6—obesity	6.15e-06	2.23e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALB—obesity	6.15e-06	2.23e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—FASN—obesity	6.09e-06	2.21e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—BCHE—obesity	6.07e-06	2.2e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NOS3—obesity	5.88e-06	2.13e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3R1—obesity	5.88e-06	2.13e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP2E1—obesity	5.85e-06	2.12e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NQO1—obesity	5.79e-06	2.1e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKT1—obesity	5.68e-06	2.06e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GCG—obesity	5.55e-06	2.01e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC2A4—obesity	5.55e-06	2.01e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYCS—obesity	5.48e-06	1.99e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CB—obesity	5.43e-06	1.97e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTGS2—obesity	5.38e-06	1.95e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GOT1—obesity	5.37e-06	1.95e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GGT1—obesity	5.37e-06	1.95e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NCOA1—obesity	5.29e-06	1.92e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—STK11—obesity	5.22e-06	1.89e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP19A1—obesity	5.22e-06	1.89e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—COMT—obesity	4.85e-06	1.76e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GNB3—obesity	4.78e-06	1.73e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARGC1A—obesity	4.78e-06	1.73e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HMOX1—obesity	4.76e-06	1.73e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GNAS—obesity	4.66e-06	1.69e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOB—obesity	4.56e-06	1.65e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LPL—obesity	4.35e-06	1.58e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GPX1—obesity	4.25e-06	1.54e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CD36—obesity	4.14e-06	1.5e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MTHFR—obesity	3.92e-06	1.42e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARA—obesity	3.85e-06	1.39e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AGT—obesity	3.72e-06	1.35e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOE—obesity	3.65e-06	1.32e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CAV1—obesity	3.62e-06	1.31e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOA1—obesity	3.61e-06	1.31e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CA—obesity	3.31e-06	1.2e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CG—obesity	3.29e-06	1.19e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARG—obesity	3.18e-06	1.15e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—POMC—obesity	3.13e-06	1.14e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—INS—obesity	3.12e-06	1.13e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CD—obesity	2.9e-06	1.05e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALB—obesity	2.86e-06	1.04e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NOS3—obesity	2.73e-06	9.92e-06	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3R1—obesity	2.73e-06	9.92e-06	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AKT1—obesity	2.7e-06	9.8e-06	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CB—obesity	2.52e-06	9.15e-06	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTGS2—obesity	2.5e-06	9.07e-06	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CA—obesity	1.54e-06	5.58e-06	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AKT1—obesity	1.26e-06	4.56e-06	CbGpPWpGaD
